NDUFAB1 and neoplasm: Despite the availability of various databases such as CancerPPD [11], ImmunoPeptidome [12,13], and PeptideCutter [14], which aid in the design of ACP candidates and the prediction of their tumor-binding epitopes [15], the effective design of ACPs remains a formidable challenge.